A61K 38/27
Growth hormone [gh], i.e. somatotropin
Official title: Growth hormone [GH], i.e. somatotropin
A61K38/27 (Growth hormone [gh], i.e. somatotropin) appears on 808 US grants and 1,048 published applications in this corpus.
Search patents in A61K- Granted patents
- 808
- Published applications
- 1,048
- Assignees
- 472
- Inventors
- 1,540
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 5 | 0 |
| 1989 | 9 | 0 |
| 1990 | 8 | 0 |
| 1991 | 15 | 0 |
| 1992 | 18 | 0 |
| 1993 | 6 | 0 |
| 1994 | 9 | 0 |
| 1995 | 12 | 0 |
| 1996 | 10 | 0 |
| 1997 | 28 | 0 |
| 1998 | 34 | 0 |
| 1999 | 32 | 0 |
| 2000 | 24 | 0 |
| 2001 | 26 | 14 |
| 2002 | 26 | 44 |
| 2003 | 20 | 56 |
| 2004 | 17 | 61 |
| 2005 | 16 | 48 |
| 2006 | 25 | 63 |
| 2007 | 12 | 57 |
| 2008 | 11 | 49 |
| 2009 | 15 | 36 |
| 2010 | 24 | 41 |
| 2011 | 21 | 41 |
| 2012 | 41 | 39 |
| 2013 | 22 | 45 |
| 2014 | 37 | 54 |
| 2015 | 37 | 44 |
| 2016 | 32 | 45 |
| 2017 | 28 | 44 |
| 2018 | 31 | 35 |
| 2019 | 29 | 56 |
| 2020 | 31 | 30 |
| 2021 | 19 | 32 |
| 2022 | 18 | 23 |
| 2023 | 14 | 20 |
| 2024 | 15 | 37 |
| 2025 | 17 | 28 |
| 2026 | 12 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of treating Prader Willi Syndrome and conditions associated with low basal metabolic rate or hyperphagia using a KATP channel opener29 Sep 2026US 12,746,244 B2Sedogen LLC
- Probiotics compositions and method of using the same to enhance growth and social function in children29 Sep 2026US 12,746,262 B2The General Hospital Corporation
- Probiotics compositions and method of using the same to enhance growth and social function in children29 Sep 2026US 12,746,264 B2The General Hospital Corporation
- Composition and methods of treatment for skin health and sleep quality using synergistically-enhanced supplementation22 Sep 2026US 12,741,004 B2Xygenyx Inc.
- Aqueous pharmaceutical composition containing fusion protein of serum albumin and growth hormone21 Jul 2026US 12,685,762 B2JCR Pharmaceuticals Co., Ltd.
- Targeting the igf-1 pathway to extend organ lifespan24 Sep 2026US 2026/0284149 A1The Regents of the University of Michigan
- Methods of treating prader willi syndrome and conditions associated with low basal metabolic rate or hyperphagia using a katp channel opener30 Jul 2026US 2026/0216203 A1Sedogen LLC
- Cancer-killing cells23 Jul 2026US 2026/0207663 A2LIfT BioSciences Ltd
- Polypeptide formulations for oral delivery7 May 2026US 2026/0124148 A1Bhami's Research Laboratory, Pvt. Ltd.
- Injectable nutrient solution30 Apr 2026US 2026/0115244 A1
Most cited
By later US patents
- Bone regeneration328US 5,824,087 AAberdeen University and Plasma Biotal Limited · 1998
- Oral compositions of proteinaceous medicaments303US 5,206,219 AApplied Analytical Industries, Inc. · 1993
- Liquid delivery compositions268US 5,780,044 AAtrix Laboratories, Inc. · 1998
- Modulated release from biocompatible polymers263US 5,656,297 AAlkermes Controlled Therapeutics, Inc. · 1997
- Liquid delivery compositions243US 5,744,153 AAtrix Laboratories, Inc. · 1998